2023 年全球常规疫苗接种覆盖率。

IF 25.4 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Camille E Jones, M Carolina Danovaro-Holliday, George Mwinnyaa, Marta Gacic-Dobo, Lauren Francis, Jan Grevendonk, Yoann Nedelec, Aaron Wallace, Samir V Sodha, Ciara Sugerman
{"title":"2023 年全球常规疫苗接种覆盖率。","authors":"Camille E Jones, M Carolina Danovaro-Holliday, George Mwinnyaa, Marta Gacic-Dobo, Lauren Francis, Jan Grevendonk, Yoann Nedelec, Aaron Wallace, Samir V Sodha, Ciara Sugerman","doi":"10.15585/mmwr.mm7343a4","DOIUrl":null,"url":null,"abstract":"<p><p>In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), a 10-year strategy to reduce vaccine-preventable disease (VPD)-associated morbidity and mortality. IA2030 goals include improving equitable vaccination coverage, halving the number of unimmunized (zero-dose) children, and increasing the introduction of new and underutilized vaccines. The COVID-19 pandemic disrupted health systems worldwide, hindering years of childhood vaccination achievements and putting global public health goals at risk. This report presents trends in World Health Organization (WHO) and UNICEF routine vaccination coverage estimates through 2023 across the 194 WHO member countries. During 2022-2023, global coverage with the first and third doses of diphtheria-tetanus-pertussis-containing vaccine (DTPcv) (89% and 84%, respectively) and the first dose of measles-containing vaccine (83%) stagnated and remained lower than prepandemic levels. The 31 WHO member countries with fragile, conflict-affected, and vulnerable (FCV) settings include approximately one half of the world's 14.5 million children who did not receive the first DTPcv dose. The introduction of new and underutilized vaccines, such as a second MCV dose in the African Region, has improved countries' overall protection against VPDs. Accelerating country-specific routine immunization and catch-up vaccination programs to reach unvaccinated and incompletely vaccinated children, especially those living in FCV settings, is critical to reducing morbidity and mortality associated with VPDs.</p>","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 43","pages":"978-984"},"PeriodicalIF":25.4000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527360/pdf/","citationCount":"0","resultStr":"{\"title\":\"Routine Vaccination Coverage - Worldwide, 2023.\",\"authors\":\"Camille E Jones, M Carolina Danovaro-Holliday, George Mwinnyaa, Marta Gacic-Dobo, Lauren Francis, Jan Grevendonk, Yoann Nedelec, Aaron Wallace, Samir V Sodha, Ciara Sugerman\",\"doi\":\"10.15585/mmwr.mm7343a4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), a 10-year strategy to reduce vaccine-preventable disease (VPD)-associated morbidity and mortality. IA2030 goals include improving equitable vaccination coverage, halving the number of unimmunized (zero-dose) children, and increasing the introduction of new and underutilized vaccines. The COVID-19 pandemic disrupted health systems worldwide, hindering years of childhood vaccination achievements and putting global public health goals at risk. This report presents trends in World Health Organization (WHO) and UNICEF routine vaccination coverage estimates through 2023 across the 194 WHO member countries. During 2022-2023, global coverage with the first and third doses of diphtheria-tetanus-pertussis-containing vaccine (DTPcv) (89% and 84%, respectively) and the first dose of measles-containing vaccine (83%) stagnated and remained lower than prepandemic levels. The 31 WHO member countries with fragile, conflict-affected, and vulnerable (FCV) settings include approximately one half of the world's 14.5 million children who did not receive the first DTPcv dose. The introduction of new and underutilized vaccines, such as a second MCV dose in the African Region, has improved countries' overall protection against VPDs. Accelerating country-specific routine immunization and catch-up vaccination programs to reach unvaccinated and incompletely vaccinated children, especially those living in FCV settings, is critical to reducing morbidity and mortality associated with VPDs.</p>\",\"PeriodicalId\":18637,\"journal\":{\"name\":\"MMWR. Morbidity and mortality weekly report\",\"volume\":\"73 43\",\"pages\":\"978-984\"},\"PeriodicalIF\":25.4000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527360/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MMWR. Morbidity and mortality weekly report\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.15585/mmwr.mm7343a4\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MMWR. Morbidity and mortality weekly report","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15585/mmwr.mm7343a4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

2020 年,世界卫生大会批准了《2030 年免疫议程》(IA2030),这是一项旨在降低与疫苗可预防疾病(VPD)相关的发病率和死亡率的 10 年战略。IA2030 的目标包括提高疫苗接种的公平覆盖率,将未接种(零剂量)儿童的人数减半,以及更多引进新疫苗和未充分利用的疫苗。COVID-19 大流行扰乱了全球的卫生系统,阻碍了多年来儿童疫苗接种的成就,并使全球公共卫生目标面临风险。本报告介绍了世界卫生组织(WHO)和联合国儿童基金会对194个WHO成员国到2023年常规疫苗接种覆盖率的估计趋势。2022-2023 年期间,全球含白喉-破伤风-百日咳疫苗 (DTPcv) 第一剂和第三剂接种率(分别为 89% 和 84%)以及含麻疹疫苗第一剂接种率(83%)停滞不前,仍低于流行前水平。世卫组织 31 个脆弱、受冲突影响和易受感染 (FCV) 的成员国包括了全球 1450 万未接种第一剂 DTPcv 的儿童中的大约一半。引入新疫苗和未充分利用的疫苗(如非洲地区的第二剂 MCV)提高了各国对 VPD 的整体防护水平。加快针对具体国家的常规免疫接种和补种计划,以覆盖未接种疫苗和未完全接种疫苗的儿童,尤其是生活在家庭、社区和学校环境中的儿童,这对于降低与VPD相关的发病率和死亡率至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Routine Vaccination Coverage - Worldwide, 2023.

In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), a 10-year strategy to reduce vaccine-preventable disease (VPD)-associated morbidity and mortality. IA2030 goals include improving equitable vaccination coverage, halving the number of unimmunized (zero-dose) children, and increasing the introduction of new and underutilized vaccines. The COVID-19 pandemic disrupted health systems worldwide, hindering years of childhood vaccination achievements and putting global public health goals at risk. This report presents trends in World Health Organization (WHO) and UNICEF routine vaccination coverage estimates through 2023 across the 194 WHO member countries. During 2022-2023, global coverage with the first and third doses of diphtheria-tetanus-pertussis-containing vaccine (DTPcv) (89% and 84%, respectively) and the first dose of measles-containing vaccine (83%) stagnated and remained lower than prepandemic levels. The 31 WHO member countries with fragile, conflict-affected, and vulnerable (FCV) settings include approximately one half of the world's 14.5 million children who did not receive the first DTPcv dose. The introduction of new and underutilized vaccines, such as a second MCV dose in the African Region, has improved countries' overall protection against VPDs. Accelerating country-specific routine immunization and catch-up vaccination programs to reach unvaccinated and incompletely vaccinated children, especially those living in FCV settings, is critical to reducing morbidity and mortality associated with VPDs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
MMWR. Morbidity and mortality weekly report
MMWR. Morbidity and mortality weekly report PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -
CiteScore
65.40
自引率
0.90%
发文量
309
期刊介绍: The Morbidity and Mortality Weekly Report (MMWR ) series is prepared by the Centers for Disease Control and Prevention (CDC). Often called “the voice of CDC,” the MMWR series is the agency’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominantly consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信